Demand is up across the board, from die-hard day traders piling into meme stocks, to exchange-traded funds and even once-cautious hedge funds now raising leverage to boost exposure.
A slate of companies are releasing or planning “Bitcoin adjacent” products that skirt U.S. regulators’ refusal to allow the largest cryptocurrency to be put in an exchange-traded fund wrapper.
The Invesco Nasdaq Biotechnology ETF (IBBQ) and Invesco PHLX Semiconductor ETF (SOXQ) will effectively cost nothing until Dec. 17, after which each will carry an expense ratio of 19 basis points.
In this week’s fund news, Morningstar provides a framework for climate change disclosures; T. Rowe launches fifth active ETF; and the space ETF UFO reminds investors 'unidentified aerial phenomena' may pose a risk.